MyFinsight
Home
Blog
About
Back
Income Statement
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)
source: myfinsight.com
Net loss
-$6,638,260
(-8.91%↓ Y/Y)
Pre-tax loss
-$6,638,260
(-8.91%↓ Y/Y)
Other income
$408,728
(27.91%↑ Y/Y)
Loss from operations
-$7,046,988
(-9.86%↓ Y/Y)
Collaboration revenue
$243,745
(48.97%↑ Y/Y)
Total operating
expenses
$7,290,733
(10.83%↑ Y/Y)
Research and development
$5,030,667
(37.33%↑ Y/Y)
General and
administrative
$2,255,603
(-22.44%↓ Y/Y)
Depreciation
$2,807
(-58.96%↓ Y/Y)
In-process research and
development
$1,656
Back